| Literature DB >> 3040335 |
Abstract
The new antiprogestin mifepristone (RU 486) was studied as a contragestive for continuous fertility control in 24 menstrual cycles. Two pregnancies out of three conceptions continued in spite of antiprogestin treatment. To date, mifepristone at the doses used appears to be inadequate for monthly use.Entities:
Mesh：
Substances：
Year: 1987 PMID： 3040335 DOI： 10.1016/0010-7824(87)90079-5
Source DB: PubMed Journal: Contraception ISSN： 0010-7824 Impact factor: 3.375